Institutional investors purchased a net $894.2 thousand shares of MDCO during the quarter ended September 2017 and now own 126.93% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN SACHS ASSET MANAGEMENT L... Bought 616.0 Thousand shares of Medicines Co
VENBIO SELECT ADVISOR LLC Bought 611.3 Thousand shares of Medicines Co
POINTSTATE CAPITAL LP Bought 577.3 Thousand shares of Medicines Co